- Medical Devices
- Thursday, 07 May 2020
New ACR Guidance Can Help Radiology Facilities Resume Non-Urgent Care
New American College of Radiology® (ACR®) guidelines can help radiology practices, as safely as possible, resume offering mammograms, oncologic and orthopedic imaging, image-guided biopsies, and other non-urgent care previously postponed due to the COVID-19 pandemic. Coronavirus cases and deaths are declining in some areas. Radiology practices in those regions are resuming such care. Published online May 6 in the Journal of the American College of Radiology (JACR), the new ACR guidance helps practices make informed decisions on when, where and how to once again offer these non-emergency services.
"Radiology practices largely followed World Health Organization, Centers for Disease Control and Prevention and ACR guidance to postpone non-urgent care. While local conditions prevent a single prescriptive strategy to resume such care, general principles can apply in most settings. These ACR recommendations can help practices safely and efficiently resume non-urgent care in areas where pandemic conditions allow," said American College of Radiology Commission on Quality and Safety Chair Jacqueline A. Bello, MD, FACR.
Read the ACR Statement on Safe Resumption of Non-Urgent Radiology Care during the COVID-19 Pandemic.
The ACR offers a variety of clinical resources for radiologists and allied health care providers — available at acr.org/covid19.
Related Industry Updates
Cardiac Resynchronisation Therapy Market Forcasted for Excellent Revenue growth by 2027
Dec 17, 2020
Hair Transplant Market, By Segmentations, Key Company Profiles & Demand Forecasts to 2020 – 2025
Jan 05, 2021
Cell Harvesting Systems Market (2020-2026) | Latest COVID19 Impact Analysis| Key Players Brandel, TERUMO BCT, INC, Thomas Scientific, SP Industries, Teleflex, Inc
Mar 09, 2021
Automated Immunoassay Analyzers Market Trends, Top Manufacturers, Opportunities and Forecast to 2027
Feb 25, 2021
Global Pancreatic Cancer Therapy Market Business Opportunity to 2027 – Top Key Player Eli Lilly and Company, F. Hoffmann-La Roche AG, Celgene Corporation, Amgen Inc., Novartis AG
Apr 01, 2021
Prostate Cancer Therapeutics Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Therapy ( Hormonal Therapy, Chemotherapy, Targeted Therapy, Immunotherapy ); Distribution Channel ( Hospitals, Specialty Clinics, Others )
Apr 19, 2021
Aesthetic Laser Market Skyrocketing Revenue by 2027 With Solta Medical, Inc., Lumenis Ltd., Cutera, Inc., Sharplight Technologies Ltd., Sciton, Inc.
Mar 23, 2021